Free Newsletter
Venter's latest revelation could save the world
The Times' Anjana Ahuja takes J. Craig Venter's latest revelation and breaks it down to some easily understood concepts. Venter is focused on creating synthetic life, taking 400 or so genes and making a microbe of his own design. Built properly, the microbe could be used to create a new generation of clean fuels. And his patent on the work, if granted, would give Venter control of those products and the vast riches they would produce. But the basic research could also point the way to a new generation of bioterror agents, which could have a dramatically different effect on the planet. Still, the work on life's simplest forms does also highlight the extraordinary collection of 30,000 genes that goes into creating a human.
- see the release on the work
- here's the column from The Times
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




